15 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
18242984	6	Constraining the amide bond in N-sulfonylated dipeptide VLA-4 antagonists.	Merck Research Laboratories
20705461	38	Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonists.	New Drug Discovery Research
20022493	35	Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists.	Merck Research Laboratories
19441819	17	Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4.	Merck Research Laboratories
19124247	9	A novel and potent VLA-4 antagonist based on trans-4-substituted cyclohexanecarboxylic acid.	Daiichi Sankyo
19072684	11	Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin.	University of California Davis
18952443	26	Identification of 4-[1-[3-chloro-4-[N'-(5-fluoro-2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist.	Daiichi Sankyo
18539454	47	Imidazopyridines as VLA-4 integrin antagonists.	Ucb Pharma
18160288	31	Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives.	Kyowa Hakko Kogyo
10866374	11	The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic.	Roche Research Center
10866373	8	Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists.	Roche Research Center
10866372	7	Carbacyclic peptide mimetics as VCAM-VLA-4 antagonists.	Roche Research Center
23899692	10	Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.	Massachusetts General Hospital and Harvard Medical School